Objectives: To evaluate the interconnection between peptidoglycan (PG) recycling, fosfomycin susceptibility and synergy between fosfomycin and b-lactams in Pseudomonas aeruginosa.
Introduction
There are multiple genes involved in the regulation of the expression of the chromosomal b-lactamase ampC, a process that is intimately linked to peptidoglycan (PG) recycling. [1] [2] [3] ampG encodes an inner membrane permease for GlcNAc-1,6-anhydromuropeptides, which are PG catabolites that, upon entry into the cytosol, are processed by the b-N-acetylglucosaminidase NagZ, to generate 1,6-anhydromuropeptides. [4] [5] [6] The 1,6-anhydromuropeptide products of NagZ are thought to induce AmpC production by interacting with the LysR-type transcriptional regulator AmpR. 7 During regular bacterial growth, 1,6-anhydromuropeptides are processed by the N-acetylanhydromuramyl-L-alanine amidase AmpD, avoiding ampC induction. 2, 8 On the other hand, during growth in the presence of strong b-lactamase inducers (such as carbapenems), large amounts of muropeptides are generated and accumulate in the cytoplasm, which leads to the AmpR-mediated induction of ampC expression. 9 It is also well-known that the mutational inactivation of AmpD leads to the accumulation of 1,6-anhydromuropeptides and high-level ampC expression, even in the absence of b-lactamase inducers, producing the classical constitutively derepressed phenotype of AmpC production. 10 Further studies have shown that Pseudomonas aeruginosa has, in addition to the cytoplasmic AmpD, two additional N-acetyl-anhydromuramyl-L-alanine amidases (AmpDh2 and AmpDh3) located in the periplasm and that their sequential inactivation leads to a stepwise upregulation of ampC expression, reaching full derepression with very high-level basal ampC expression and b-lactam resistance in the triple mutant. 11, 12 More recent work showed, however, that one-step high-level resistance V C The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com in P. aeruginosa frequently results from the inactivation of dacB, encoding the non-essential low molecular mass PBP4. 13 The DD-carboxypeptidase and endopeptidase PBP4 has been shown to play a sentinel role for cell wall damage by b-lactams, raising a complex resistance response, triggering overproduction of the chromosomal b-lactamase AmpC and the specific activation of the CreBC (BlrAB) two-component regulator. [13] [14] [15] Finally, recent work shows that other low molecular mass PBPs, particularly the dacC-encoded PBP5, also play a relevant role in PG metabolism and ampC expression. 16 We and others have previously shown that targeting PG recycling (such as removing NagZ or AmpG activity) is a potentially useful strategy to overcome (AmpC-driven) b-lactam resistance in P. aeruginosa and other Gram-negative bacilli. 5, [17] [18] [19] [20] [21] [22] On the other hand, fosfomycin, a phosphoenolpyruvate analogue, binds MurA (UDP-N-acetylglucosamine enolpyruvyl transferase), preventing the formation of UDP-N-acetylmuramic acid during the first step in PG biosynthesis, leading to bacterial cell lysis and death. 23, 24 However, interestingly, recent work has demonstrated the existence in Pseudomonas species of an N-acetylmuramic acid salvage pathway coupled to the above-described PG recycling process, which may bypass de novo synthesis and, therefore, fosfomycin activity, contributing to intrinsic resistance. 25, 26 Thus, results from these, and above works, suggest that blocking PG recycling may simultaneously modulate b-lactam and fosfomycin susceptibility, adding a further dimension to this research field from the perspective of antimicrobial drug discovery. Therefore, in this work we analysed the activity of fosfomycin in a large collection of P. aeruginosa mutants (of laboratory and clinical strains) on key components of PG recycling and ampC expression pathways though the determination of MICs, population analysis, killing curves alone or combined with b-lactams, and in the presence of a small molecule inhibitor of PG recycling.
Materials and methods

Strains and susceptibility testing
The panel of 47 bacterial strains used in this study is listed in Table 1 . Fosfomycin MICs were determined by the broth microdilution method as recommended by EUCAST (www.eucast.org). The MICs were also assessed using Etest strips (bioMérieux, France) on Mueller-Hinton (MH) agar with two different inocula: standard 1 Â 10 8 cfu/mL inoculum (turbidity equivalent to that of a 0.5 McFarland standard) and 1/100 dilution (1 Â 10 6 cfu/mL) of the standard suspension, recently shown to correlate better with broth microdilution MICs. 27 All determinations were performed in at least two independent occasions and range values are shown. Additionally, PAO1 triplicate broth microdilution fosfomycin MICs were determined in the presence and absence of a 5 mM concentration of the NagZ inhibitor PUGNAc. 5 PUGNAc was synthesized according to previously described procedures. 28 Population analysis of fosfomycin susceptibility 
Generation and analysis of spontaneous fosfomycinresistant mutants
For the isolation and characterization of fosfomycin-resistant mutants, PAO1, PADnZ, PADG, PADR and PADDDh2Dh3 strains were inoculated into flasks containing 10 mL MHB and incubated overnight at 37 C with shaking. One hundred microlitres of each of three independent overnight cultures was plated on MH agar supplemented with 128 mg/L fosfomycin and incubated at 37 C for 24 h. From each plate, a single colony was isolated and purified on MH agar containing fosfomycin at the same concentration. Chromosomal DNA was isolated from each of the mutants and the WT strain and their glpT genes were PCR amplified and sequenced using previously described primers. 29 The resulting sequences were then compared with those available in the GenBank database (www.ncbi.nih.gov/BLAST).
Killing curves
For killing kinetics studies, overnight MHB cultures of PAO1, PADnZ, PADDDh2Dh3 and PADG were diluted (1/100) in fresh medium and incubated (37 C, 180 rpm) to an OD 600 of 0.2 (mid-log-phase growth). Killing curves were then initiated by inoculating 0.01 mL into microtitre wells with 0.2 mL MHB (10 7 cfu/mL initial concentration) containing different concentrations of fosfomycin (16 or Table 1 shows the broth microdilution and Etest (standard and low inoculum) fosfomycin MICs for the panel of 47 P. aeruginosa mutants (of laboratory and clinical strains) on key components of PG recycling and ampC expression pathways tested; Figure 1 shows a representative picture of Etest MICs for selected relevant strains. As previously described, 27 overall, low inoculum Etest MICs correlated better with broth microdilution MICs. WT PAO1 MICs ranged 96-128 mg/L for the standard inoculum Etest, 48-64 mg/L for low inoculum Etest and 64 mg/L for broth microdilution. Nonsignificant, within one 2-fold dilution, differences were observed for several strains; however, those defective in AmpG, NagZ or all three AmpD amidases showed a marked increase in fosfomycin susceptibility (at least two 2-fold dilutions).
Results
As a proof of concept validation of NagZ as the target for increasing fosfomycin susceptibility, MICs were also determined by broth microdilution in the presence of the NagZ inhibitor PUGNAc. Remarkably, PAO1 fosfomycin MICs were reduced consistently (in triplicate experiments) from 48 to 24 mg/L in the presence of a 5 mM concentration of PUGNAc.
Fosfomycin hypersusceptibility of the ampG, nagZ and triple ampD mutants was also clearly confirmed in the performed population analysis, whereas hypersusceptibility of the ampR mutant was, at best, marginal ( Figure 2) . However, population analysis also indicated that $10 3 cfu/mL persisted with concentrations up to 512 mg/L for all the mutants; numbers very similar to those observed for the WT strain ( Figure 2 ). This should mean that frequent ($10
) spontaneous fosfomycin mutants show high-level resistance even when originated from an ampG, nagZ or triple ampD mutant background. Indeed, two independent colonies growing on 128 mg/L fosfomycin plates from strains PAO1, and the ampG, nagZ and triple ampD mutants were purified and Fosfomycin susceptibility and cell wall recycling JAC Hamou-Segarra et al.
checked for the presence of mutations in glpT. As expected, all the studied mutants showed mutations in this gene, well known to be the cause of frequent high-level fosfomycin resistance development. 29 Interestingly, three of the eight mutants studied (one each derived from PAO1, PADnZ and PADG) showed mutations involving a 6 bp (GCCATC) repeat that was mutated to either gain or lose one copy as previously described. 27 Killing kinetics studies were performed in WT PAO1 and the nagZ, ampG and triple ampD mutants using two different concentrations of fosfomycin (16 or 128 mg/L), imipenem (1 or 4 mg/L) or their combination and results are shown in Figures 3 and 4 . Imipenem concentrations chosen were those of the EUCAST susceptibility breakpoint (4 mg/L) and 0.5Â WT PAO1 MIC (2 mg/L). The imipenem MIC of the triple ampD mutant is the same as that of PAO1 but the nagZ (1 mg/L) and particularly the ampG (0.5 mg/L) mutants are known to be hypersusceptible. 17, 18 Since there are no current breakpoints, fosfomycin concentrations tested included the ECOFF (128 mg/L) and the MIC of the investigated mutants (16 mg/L). As evidenced in Figures 3 and 4 , fosfomycin bactericidal activity was much higher for the nagZ, ampG Fosfomycin susceptibility and cell wall recycling JAC and triple ampD mutants than for the WT strain at both concentrations tested. However, at these concentrations, regrowth, due to the selection of resistant mutant populations, was evidenced for all strains. On the other hand, imipenem alone at the higher concentration ( Figure 4) showed potent bactericidal activity for all strains tested, albeit it was a bit lower for the triple ampD mutant. Major differences were observed, however, with the low imipenem concentration (Figure 3) , showing potent bactericidal activity only for the ampG mutant. Interestingly, imipenem/fosfomycin combinations showed synergistic killing compared with the individual regimens, particularly at low concentrations, with the WT strain and the nagZ and triple ampD mutants; imipenem activity was already very high in the ampG mutant and was not much further enhanced by fosfomycin (Figure 3) . Likewise, the potent bactericidal activity of imipenem at the higher concentration resulted in the absence of synergy with fosfomycin, except for the triple ampD mutant (Figure 4) .
Discussion
In previous studies, we have shown that targeting PG recycling is a potentially useful strategy to overcome (AmpC-driven) b-lactam resistance in P. aeruginosa and other Gram-negative bacilli. 5, 17, 18, 21 Indeed, these studies showed that the inactivation of NagZ or AmpG restores WT b-lactam susceptibility of laboratory and clinical strains showing AmpC hyperproduction. Moreover, the inactivation of AmpG is shown to restore WT imipenem MICs for pan-b-lactam-resistant clinical strains showing AmpC hyperproduction, OprD inactivation and efflux pump overexpression. 18 Likewise, population analyses revealed that inactivation of NagZ or AmpG prevent the emergence of (AmpC-hyperproducing) ceftazidime-resistant mutants from WT PAO1 strain. 17, 18 Moreover, NagZ inhibitors such, as PUGNAc, have been shown to mitigate AmpC-driven resistance in vitro. 5, 17, 21, 22, 28 On the other hand, fosfomycin has emerged in recent years as a potentially useful agent for combined treatment of infections by MDR Gram-negative pathogens, including P. aeruginosa. However, WT P. aeruginosa shows higher MICs than Enterobacteriaceae and is considered to be intrinsically non-susceptible to fosfomycin. Recent studies have suggested that intrinsic resistance is at least partially due to the existence of an N-acetylmuramic acid salvage pathway coupled to the PG recycling process, which may bypass de novo synthesis, and therefore fosfomycin activity, contributing to intrinsic resistance. 25, 26 We indeed show that the inactivation of NagZ or AmpG significantly enhances fosfomycin susceptibility of P. aeruginosa, decreasing MICs to values closer to those of WT Escherichia coli (EUCAST ECOFF 8 mg/L), both in laboratory and clinical strains. Moreover, our results also indicate that the inactivation of the three AmpD amidases, conferring b-lactam resistance through AmpC overexpression, causes a significant fosfomycin hypersusceptibility. Indeed, this effect is expected to be also a consequence of blocking of PG recycling since AmpD activity is known to be required for the process.
1-3 Thus our results indicate that blocking of PG recycling through inhibition of the AmpG, NagZ or the three AmpD amidases increases the susceptibility of P. aeruginosa to fosfomycin. Hamou-Segarra et al.
As shown previously for b-lactams, in this work we demonstrate that the NagZ inhibitor PUGNAc significantly increases fosfomycin susceptibility of a WT P. aeruginosa in vitro, validating NagZ as an interesting target to increase simultaneously the activity of b-lactams and fosfomycin.
However, population analysis revealed that blocking of the PG recycling through NagZ or AmpG inactivation does not prevent the frequent emergence of high-level fosfomycin-resistant mutants caused by the mutation of the glycerol 3-phosphate transporter (GlpT). Indeed, concerning reports have shown that fosfomycin resistance in P. aeruginosa emerges through GlpT mutation at a high frequency and without significant fitness cost. 30, 31 Regrowth of fosfomycin-resistant populations were also clearly evidenced in the killing-curve experiments. However, a clear synergy between fosfomycin and imipenem was evidenced for the WT strain, the AmpC-hyperproducing strain (triple AmpD mutant) and the NagZ and AmpG mutants. Moreover, regrowth of resistance mutants was not evidenced for the combinations. However, results should be interpreted with caution, since previous works have shown that simultaneous emergence of fosfomycin and imipenem resistance may occur in vitro.
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In conclusion, we have shown that blocking of the PG recycling through inactivation or inhibition of the AmpG or NagZ simultaneously enhances b-lactam and fosfomycin susceptibility. Moreover, we show that certain mechanisms leading to AmpC-driven b-lactam resistance also enhance fosfomycin susceptibility as a consequence of PG recycling inhibition. Thus, PG recycling inhibitors are envisaged as useful adjuvants in the treatment of P. aeruginosa infections and therefore further development of these molecules is encouraged. Fosfomycin susceptibility and cell wall recycling JAC
